Morten Hansen
Morten Hansen
National Center for Cancer Immune Therapy at Copenhagen University Hospital
Verified email at
Cited by
Cited by
The effect of short-chain fatty acids on human monocyte-derived dendritic cells
C Nastasi, M Candela, CM Bonefeld, C Geisler, M Hansen, T Krejsgaard, ...
Scientific reports 5 (1), 16148, 2015
Predictors of responses to immune checkpoint blockade in advanced melanoma
N Jacquelot, MP Roberti, DP Enot, S Rusakiewicz, N Ternès, S Jegou, ...
Nature communications 8 (1), 592, 2017
Butyrate and propionate inhibit antigen-specific CD8+ T cell activation by suppressing IL-12 production by antigen-presenting cells
C Nastasi, S Fredholm, A Willerslev-Olsen, M Hansen, CM Bonefeld, ...
Scientific reports 7 (1), 14516, 2017
The role of dendritic cells in cancer
M Hansen, MH Andersen
Seminars in immunopathology 39, 307-316, 2017
CCL22-specific T Cells: Modulating the immunosuppressive tumor microenvironment
E Martinenaite, S Munir Ahmad, M Hansen, Ö Met, MW Westergaard, ...
Oncoimmunology 5 (11), e1238541, 2016
Tumor infiltrating lymphocyte therapy for ovarian cancer and renal cell carcinoma
R Andersen, M Donia, MCW Westergaard, M Pedersen, M Hansen, ...
Human vaccines & immunotherapeutics 11 (12), 2790-2795, 2015
Dendritic cell vaccination in combination with docetaxel for patients with metastatic castration-resistant prostate cancer: A randomized phase II study
P Kongsted, TH Borch, E Ellebaek, TZ Iversen, R Andersen, Ö Met, ...
Cytotherapy 19 (4), 500-513, 2017
In-chip fabrication of free-form 3D constructs for directed cell migration analysis
MH Olsen, GM Hjortø, M Hansen, Ö Met, IM Svane, NB Larsen
Lab on a Chip 13 (24), 4800-4809, 2013
Differential CCR7 targeting in dendritic cells by three naturally occurring CC-chemokines
GM Hjortø, O Larsen, A Steen, V Daugvilaite, C Berg, S Fares, M Hansen, ...
Frontiers in Immunology 7, 218657, 2016
Non-invasive biomarkers derived from the extracellular matrix associate with response to immune checkpoint blockade (anti-CTLA-4) in metastatic melanoma patients
C Jensen, DH Madsen, M Hansen, H Schmidt, IM Svane, MA Karsdal, ...
Journal for Immunotherapy of Cancer 6, 1-10, 2018
Expansion of circulating CD56bright natural killer cells in patients with JAK2‐positive chronic myeloproliferative neoplasms during treatment with interferon‐α
CH Riley, M Hansen, MK Brimnes, H Hans C., OW Bjerrum, P Straten, ...
European Journal of Haematology, 2014
Methods to Improve Adoptive T-Cell Therapy for Melanoma: IFN-γ Enhances Anticancer Responses of Cell Products for Infusion
M Donia, M Hansen, SL Sendrup, TZ Iversen, E Ellebæk, MH Andersen, ...
Journal of Investigative Dermatology, 2012
Injection molded chips with integrated conducting polymer electrodes for electroporation of cells
KØ Andresen, M Hansen, M Matschuk, ST Jepsen, HS Sørensen, P Utko, ...
Journal of Micromechanics and Microengineering 20, 055010, 2010
Comparison of clinical grade type 1 polarized and standard matured dendritic cells for cancer immunotherapy
M Hansen, GM Hjortø, M Donia, Ö Met, NB Larsen, MH Andersen, ...
Vaccine 31 (4), 639-646, 2013
PD-L1 peptide co-stimulation increases immunogenicity of a dendritic cell-based cancer vaccine
S Munir Ahmad, E Martinenaite, M Hansen, N Junker, TH Borch, Ö Met, ...
Oncoimmunology 5 (8), e1202391, 2016
Cellular Based Cancer Vaccines: Type 1 Polarization of Dendritic Cells
M Hansen, O Met, IM Svane, MH Andersen
Current Medicinal Chemistry 19 (25), 4239-4246, 2012
mRNA-transfected dendritic cell vaccine in combination with metronomic cyclophosphamide as treatment for patients with advanced malignant melanoma
TH Borch, L Engell-Noerregaard, T Zeeberg Iversen, E Ellebaek, Ö Met, ...
Oncoimmunology 5 (9), e1207842, 2016
Granzyme B degraded type IV collagen products in serum identify melanoma patients responding to immune checkpoint blockade
C Jensen, D Sinkeviciute, DH Madsen, P Önnerfjord, M Hansen, ...
Cancers 12 (10), 2786, 2020
Interferon‐α induces marked alterations in circulating regulatory T cells, NK cell subsets, and dendritic cells in patients with JAK 2V617F‐positive essential thrombocythemia …
CH Riley, MK Brimnes, M Hansen, MK Jensen, HC Hasselbalch, L Kjaer, ...
European Journal of Haematology 97 (1), 83-92, 2016
Therapeutic cancer vaccination with a peptide derived from the calreticulin exon 9 mutations induces strong cellular immune responses in patients with CALR-mutant chronic …
J Handlos Grauslund, MO Holmström, NG Jørgensen, U Klausen, ...
Frontiers in oncology 11, 637420, 2021
The system can't perform the operation now. Try again later.
Articles 1–20